MedTrace Logo

A Study of Experimental Medication BMS-986278 Given to Healthy Participants

NCT03429933 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2019-10-01

No results posted yet for this study

Summary

The purpose of this study is to investigate experimental medication BMS-986278 given to healthy participants.

Conditions

  • Healthy Participants

Interventions

DRUG

BMS-986278

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-07
Primary Completion
2019-03-02
Completion
2019-03-02
FDA Drug
Yes

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429933 on ClinicalTrials.gov